Global Inflammatory Bowel Disease (IBD) Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Inflammatory Bowel Disease (IBD) Drugs Market Size, Share and Analysis

The global Inflammatory Bowel Disease (IBD) Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Inflammatory Bowel Disease (IBD) Drugs Industry Forecast looks at past sales and reviews total world Inflammatory Bowel Disease (IBD) Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Inflammatory Bowel Disease (IBD) Drugs sales for 2025 through 2031. With Inflammatory Bowel Disease (IBD) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inflammatory Bowel Disease (IBD) Drugs industry. This Insight Report provides a comprehensive analysis of the global Inflammatory Bowel Disease (IBD) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Inflammatory Bowel Disease (IBD) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Inflammatory Bowel Disease (IBD) Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inflammatory Bowel Disease (IBD) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inflammatory Bowel Disease (IBD) Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Inflammatory Bowel Disease (IBD) Drugs market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Aminosalicylate &nbsp;&nbsp;&nbsp; Corticosteroid Hormone &nbsp;&nbsp;&nbsp; Immunosuppressants &nbsp;&nbsp;&nbsp; Biological Agents Segmentation by Application: &nbsp;&nbsp;&nbsp; Ulceratory Colitis &nbsp;&nbsp;&nbsp; Crohns Disease This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Abbott Laboratories &nbsp;&nbsp;&nbsp; Biocon Ltd &nbsp;&nbsp;&nbsp; Johnson and Johnson &nbsp;&nbsp;&nbsp; Novartis AG &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Quest Medical &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Takeda Pharmaceutical &nbsp;&nbsp;&nbsp; UCB Pharma &nbsp;&nbsp;&nbsp; AbbVie &nbsp;&nbsp;&nbsp; Zhejiang Hisun Pharmaceutical Co.,Ltd. &nbsp;&nbsp;&nbsp; North China Pharmaceutical Co., Ltd. &nbsp;&nbsp;&nbsp; Zhejiang Zhebei Pharmaceutical Co., Ltd. &nbsp;&nbsp;&nbsp; Huadong Medicine Co., Ltd. &nbsp;&nbsp;&nbsp; Shenzhen Salubris Pharmaceuticals Co.,Ltd. &nbsp;&nbsp;&nbsp; Heilongjiang Tianhong Pharmaceutical Co., Ltd.

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Size (2020-2031) &nbsp;2.1.2 Inflammatory Bowel Disease (IBD) Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Inflammatory Bowel Disease (IBD) Drugs by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Inflammatory Bowel Disease (IBD) Drugs Segment by Type &nbsp;2.2.1 Aminosalicylate &nbsp;2.2.2 Corticosteroid Hormone &nbsp;2.2.3 Immunosuppressants &nbsp;2.2.4 Biological Agents &nbsp;2.3 Inflammatory Bowel Disease (IBD) Drugs Market Size by Type &nbsp;2.3.1 Inflammatory Bowel Disease (IBD) Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Inflammatory Bowel Disease (IBD) Drugs Market Size Market Share by Type (2020-2025) &nbsp;2.4 Inflammatory Bowel Disease (IBD) Drugs Segment by Application &nbsp;2.4.1 Ulceratory Colitis &nbsp;2.4.2 Crohn's Disease &nbsp;2.5 Inflammatory Bowel Disease (IBD) Drugs Market Size by Application &nbsp;2.5.1 Inflammatory Bowel Disease (IBD) Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Inflammatory Bowel Disease (IBD) Drugs Market Size Market Share by Application (2020-2025) 3 Inflammatory Bowel Disease (IBD) Drugs Market Size by Player &nbsp;3.1 Inflammatory Bowel Disease (IBD) Drugs Market Size Market Share by Player &nbsp;3.1.1 Global Inflammatory Bowel Disease (IBD) Drugs Revenue by Player (2020-2025) &nbsp;3.1.2 Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Inflammatory Bowel Disease (IBD) Drugs Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Inflammatory Bowel Disease (IBD) Drugs by Region &nbsp;4.1 Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2020-2025) &nbsp;4.2 Global Inflammatory Bowel Disease (IBD) Drugs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Inflammatory Bowel Disease (IBD) Drugs Market Size Growth (2020-2025) &nbsp;4.4 APAC Inflammatory Bowel Disease (IBD) Drugs Market Size Growth (2020-2025) &nbsp;4.5 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2020-2025) &nbsp;5.2 Americas Inflammatory Bowel Disease (IBD) Drugs Market Size by Type (2020-2025) &nbsp;5.3 Americas Inflammatory Bowel Disease (IBD) Drugs Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2020-2025) &nbsp;6.2 APAC Inflammatory Bowel Disease (IBD) Drugs Market Size by Type (2020-2025) &nbsp;6.3 APAC Inflammatory Bowel Disease (IBD) Drugs Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2020-2025) &nbsp;7.2 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Type (2020-2025) &nbsp;7.3 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs by Region (2020-2025) &nbsp;8.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Inflammatory Bowel Disease (IBD) Drugs Market Forecast &nbsp;10.1 Global Inflammatory Bowel Disease (IBD) Drugs Forecast by Region (2026-2031) &nbsp;10.1.1 Global Inflammatory Bowel Disease (IBD) Drugs Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.1.3 APAC Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.1.4 Europe Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.1.5 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.2 Americas Inflammatory Bowel Disease (IBD) Drugs Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.2.2 Canada Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.2.3 Mexico Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.2.4 Brazil Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.3 APAC Inflammatory Bowel Disease (IBD) Drugs Forecast by Region (2026-2031) &nbsp;10.3.1 China Inflammatory Bowel Disease (IBD) Drugs Market Forecast &nbsp;10.3.2 Japan Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.3.3 Korea Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.3.4 Southeast Asia Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.3.5 India Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.3.6 Australia Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.4 Europe Inflammatory Bowel Disease (IBD) Drugs Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.4.2 France Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.4.3 UK Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.4.4 Italy Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.4.5 Russia Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.5 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.5.2 South Africa Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.5.3 Israel Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.5.4 Turkey Market Inflammatory Bowel Disease (IBD) Drugs Forecast &nbsp;10.6 Global Inflammatory Bowel Disease (IBD) Drugs Forecast by Type (2026-2031) &nbsp;10.7 Global Inflammatory Bowel Disease (IBD) Drugs Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Inflammatory Bowel Disease (IBD) Drugs Forecast 11 Key Players Analysis &nbsp;11.1 Abbott Laboratories &nbsp;11.1.1 Abbott Laboratories Company Information &nbsp;11.1.2 Abbott Laboratories Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.1.3 Abbott Laboratories Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Abbott Laboratories Main Business Overview &nbsp;11.1.5 Abbott Laboratories Latest Developments &nbsp;11.2 Biocon Ltd &nbsp;11.2.1 Biocon Ltd Company Information &nbsp;11.2.2 Biocon Ltd Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.2.3 Biocon Ltd Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Biocon Ltd Main Business Overview &nbsp;11.2.5 Biocon Ltd Latest Developments &nbsp;11.3 Johnson and Johnson &nbsp;11.3.1 Johnson and Johnson Company Information &nbsp;11.3.2 Johnson and Johnson Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.3.3 Johnson and Johnson Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Johnson and Johnson Main Business Overview &nbsp;11.3.5 Johnson and Johnson Latest Developments &nbsp;11.4 Novartis AG &nbsp;11.4.1 Novartis AG Company Information &nbsp;11.4.2 Novartis AG Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.4.3 Novartis AG Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Novartis AG Main Business Overview &nbsp;11.4.5 Novartis AG Latest Developments &nbsp;11.5 Pfizer &nbsp;11.5.1 Pfizer Company Information &nbsp;11.5.2 Pfizer Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.5.3 Pfizer Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Pfizer Main Business Overview &nbsp;11.5.5 Pfizer Latest Developments &nbsp;11.6 Quest Medical &nbsp;11.6.1 Quest Medical Company Information &nbsp;11.6.2 Quest Medical Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.6.3 Quest Medical Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Quest Medical Main Business Overview &nbsp;11.6.5 Quest Medical Latest Developments &nbsp;11.7 Sanofi &nbsp;11.7.1 Sanofi Company Information &nbsp;11.7.2 Sanofi Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.7.3 Sanofi Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Sanofi Main Business Overview &nbsp;11.7.5 Sanofi Latest Developments &nbsp;11.8 Takeda Pharmaceutical &nbsp;11.8.1 Takeda Pharmaceutical Company Information &nbsp;11.8.2 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.8.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Takeda Pharmaceutical Main Business Overview &nbsp;11.8.5 Takeda Pharmaceutical Latest Developments &nbsp;11.9 UCB Pharma &nbsp;11.9.1 UCB Pharma Company Information &nbsp;11.9.2 UCB Pharma Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.9.3 UCB Pharma Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 UCB Pharma Main Business Overview &nbsp;11.9.5 UCB Pharma Latest Developments &nbsp;11.10 AbbVie &nbsp;11.10.1 AbbVie Company Information &nbsp;11.10.2 AbbVie Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.10.3 AbbVie Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 AbbVie Main Business Overview &nbsp;11.10.5 AbbVie Latest Developments &nbsp;11.11 Zhejiang Hisun Pharmaceutical Co.,Ltd. &nbsp;11.11.1 Zhejiang Hisun Pharmaceutical Co.,Ltd. Company Information &nbsp;11.11.2 Zhejiang Hisun Pharmaceutical Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.11.3 Zhejiang Hisun Pharmaceutical Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Zhejiang Hisun Pharmaceutical Co.,Ltd. Main Business Overview &nbsp;11.11.5 Zhejiang Hisun Pharmaceutical Co.,Ltd. Latest Developments &nbsp;11.12 North China Pharmaceutical Co., Ltd. &nbsp;11.12.1 North China Pharmaceutical Co., Ltd. Company Information &nbsp;11.12.2 North China Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.12.3 North China Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 North China Pharmaceutical Co., Ltd. Main Business Overview &nbsp;11.12.5 North China Pharmaceutical Co., Ltd. Latest Developments &nbsp;11.13 Zhejiang Zhebei Pharmaceutical Co., Ltd. &nbsp;11.13.1 Zhejiang Zhebei Pharmaceutical Co., Ltd. Company Information &nbsp;11.13.2 Zhejiang Zhebei Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.13.3 Zhejiang Zhebei Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Zhejiang Zhebei Pharmaceutical Co., Ltd. Main Business Overview &nbsp;11.13.5 Zhejiang Zhebei Pharmaceutical Co., Ltd. Latest Developments &nbsp;11.14 Huadong Medicine Co., Ltd. &nbsp;11.14.1 Huadong Medicine Co., Ltd. Company Information &nbsp;11.14.2 Huadong Medicine Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.14.3 Huadong Medicine Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Huadong Medicine Co., Ltd. Main Business Overview &nbsp;11.14.5 Huadong Medicine Co., Ltd. Latest Developments &nbsp;11.15 Shenzhen Salubris Pharmaceuticals Co.,Ltd. &nbsp;11.15.1 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Company Information &nbsp;11.15.2 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.15.3 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Main Business Overview &nbsp;11.15.5 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Latest Developments &nbsp;11.16 Heilongjiang Tianhong Pharmaceutical Co., Ltd. &nbsp;11.16.1 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information &nbsp;11.16.2 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product Offered &nbsp;11.16.3 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Main Business Overview &nbsp;11.16.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Latest Developments 12 Research Findings and Conclusion

Report	Global Inflammatory Bowel Disease (IBD) Drugs Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI49959

Buyer Information

Order Summary